HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

SAK3 Administration Improves Spine Abnormalities and Cognitive Deficits in AppNL-G-F/NL-G-F Knock-in Mice by Increasing Proteasome Activity through CaMKII/Rpt6 Signaling.

Abstract
Alzheimer's disease (AD) is the most common form of dementia and is characterized by neuropathological hallmarks consisting of accumulation of extracellular amyloid-β (Aβ) plaques and intracellular neurofibrillary tangles (NFT). Recently, we have identified a new AD therapeutic candidate, ethyl-8'-methyl-2',4-dioxo-2-(piperidin-1-yl)-2'H-spiro[cyclopentane-1,3'-imidazo [1,2-a] pyridin]-2-ene-3-carboxylate (SAK3), which ameliorates the AD-like pathology in AppNL-F/NL-F knock-in mice. However, the detailed mechanism underlying the therapeutic effects of SAK3 remains unclear. In this study, we found that SAK3 administration improved the reduced proteasome activity through the activation of CaMKII/Rpt6 signaling in AppNL-F/NL-F knock-in (NL-G-F) mice. Moreover, spine abnormalities observed in NL-G-F mice were significantly reversed by SAK3 administration. Along with this, cognitive impairments found in NL-G-F mice were markedly ameliorated by SAK3. In summary, our data suggest that SAK3 administration increases the activity of the proteasome via activation of the CaMKII/Rpt6 signaling pathway, contributing to improvements in spine abnormalities and cognitive deficits in NL-G-F mice. Overall, our findings suggest that SAK3 might be a new attractive drug candidate, representing a new mechanism for the treatment of AD pathology.
AuthorsHisanao Izumi, Ichiro Kawahata, Yasuharu Shinoda, Fred J Helmstetter, Kohji Fukunaga
JournalInternational journal of molecular sciences (Int J Mol Sci) Vol. 21 Issue 11 (May 28 2020) ISSN: 1422-0067 [Electronic] Switzerland
PMID32481611 (Publication Type: Journal Article)
Chemical References
  • APP protein, mouse
  • Amyloid beta-Peptides
  • Amyloid beta-Protein Precursor
  • Imidazoles
  • Psmc5 protein, mouse
  • SAK3 compound
  • Spiro Compounds
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2
  • Proteasome Endopeptidase Complex
  • ATPases Associated with Diverse Cellular Activities
Topics
  • ATPases Associated with Diverse Cellular Activities (genetics)
  • Alzheimer Disease (metabolism)
  • Amyloid beta-Peptides (metabolism)
  • Amyloid beta-Protein Precursor (genetics)
  • Animals
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2 (genetics)
  • Cognitive Dysfunction (drug therapy, metabolism)
  • Dendritic Spines (metabolism)
  • Female
  • Gene Knock-In Techniques
  • Imidazoles (pharmacology)
  • Liver (metabolism)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Neurofibrillary Tangles (metabolism)
  • Phosphorylation
  • Plaque, Amyloid (metabolism)
  • Proteasome Endopeptidase Complex (genetics, metabolism)
  • Signal Transduction
  • Spine (pathology)
  • Spiro Compounds (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: